| abstract |
FIELD: medicine.SUBSTANCE: group of inventions relates to medicine and concerns a method for stabilizing a human blood plasma protein with a molecular weight greater than 10 kDa by adding melycytosis to a solution containing a human blood plasma protein with a molecular weight greater than 10 kDa, which is pharmaceutically or a biologically significant human blood plasma protein or recombinant human plasma protein selected from a group consisting of fibrinogen, factor FVIIa, von Willebrand factor, antithrombin, C1 inhibitor, polyclonal antibodies (IgG), monoclonal antibodies, factor H, factor I, hepatocyte growth factor, plasminogen, α-1-microglobulin, vWF and α-antitrypsin. Group of inventions also relates to the use of melicycosis for stabilizing said human plasma proteins.EFFECT: group of inventions provides stabilizing a solution containing said human blood plasma proteins.24 cl, 11 tbl, 6 ex |